KAREN CLEMENT: Open Payments
NPI 1063036937 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 22 payments from 9 companies in 2025. Trend: 2023 $844 · 2024 $172 · 2025 $551
Food & beverage: $474Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $160 |
| ABBVIE INC. | 5 | $120 |
| PFIZER INC. | 2 | $66 |
| Madrigal Pharmaceuticals | 2 | $51 |
| Lilly USA, LLC | 2 | $43 |
| Celltrion USA Inc. | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: TREMFYA, XELJANZ, MAVYRET, REZDIFFRA, OMVOH, VEGZELMA, RINVOQ, VOWST.
Industry payments across AK — which companies pay providers there.
